OMEROS CORPORATION
OMERPharmaceutical Preparations · Avg daily volume 1.4M · fiscal year ends Dec$13.21−0.80−5.71%Volume 2.0M+48% vs avg
Week
OMEROMEROS CORPORATION · 1DNov 20, 2026
O13.78H13.88L13.07C13.21−0.80 (−5.71%)ADR5.9%
This week, day 5 of 5−24.5%range37.6%closed at11% of rangevol1.9× 10-wk avg
Vol2.0M1.5× avg
SMA 10
SMA 2016.91−21.9%
SMA 5017.83−25.9%
SMA 20013.84−4.6%
Close Nov 20, 2026
Quarterly earnings
Latest filing: 10-Q, 2026-11-16Jun ’24FQ2 ’24
Sep ’24FQ3 ’24
Dec ’24Q4FQ4 ’24
Mar ’25FQ1 ’25
Jun ’25FQ2 ’25
Sep ’25FQ3 ’25
Dec ’25Q4FQ4 ’25
Mar ’26FQ1 ’26
Jun ’26FQ2 ’26
Sep ’26FQ3 ’26
EPS
EPS
−$0.97
−$0.56
−$0.55
−$0.58
−$0.43
−$0.47
$1.42
$0.62
$0.15
−$0.79
% chg
−64%
+7%
−267%
+8%
+56%
+16%
+358%
+207%
+135%
−68%
Sales
–
–
–
0
0
0
–
9.9M
28.5M
35.9M
% chg
–
–
–
–
–
–
–
–
–
–
Filed
08/14
11/13
03/31
05/15
08/14
11/13
03/31
05/13
08/12
11/16
EPS growth ≥ 25%0–25%fallingno comparison
Source: SEC EDGAR 10-Q and 10-K filings, loaded the first time a stock is opened and refreshed daily. Q4 = full year minus the first three quarters. Growth from a loss is measured against the size of the loss (−$1 → $2 = +300%). Analyst estimates are not in EDGAR.